|
1）Starzl TE, Marchiro TL, Holmes JH, et al. Renal homografts in patients with major donor recipient blood group incompatibilities. Surgery. 1964; 55: 195-200
|
|
|
|
2）Gleason RE, Murray JE. Report from kidney transplant registry: Analysis of variables in the function of human kidney transplants. Transplantation. 1967; 52: 343-59
|
|
|
|
|
|
3）Slapak M, Naik RB, Lee HA, et al. Renal transplant in a patient with major donor-recipient blood group incompatibility. Reversal of acute rejection by the use of modified plasmapheresis. Transplantation. 1981; 31: 4-7
|
|
|
|
|
4）Alexandre GPJ, Bruyere MDE, Piason Y, et al. Human ABO incompatible living donor renal homografts. Neth J Med. 1985; 28: 231-4
|
|
|
|
|
|
5）高橋公太, 阿岸鉄三, 田邊一成, 他. 腎移植拡大のための血液浄化療法―とくにABO血液型不適合と既存抗体陽性例の生体腎移植. 日外会誌. 1990; 91; 1272-6
|
|
|
|
|
6）齋藤和英, 高橋公太. 日本におけるABO血液型不適合腎移植の統計2012. ABO血液型不適合移植の新戦略2013. 東京: 日本医学館; 2013. p.3-17
|
|
|
|
|
|
7）Takahashi K, Saito K, Takahara S, et al. Excellent long-term outcome of ABO-incompatible living donor kidney transplantation in Japan. Am J Transplant. 2004; 4: 1089-96
|
|
|
|
|
|
8）Takahashi K. A new concept of accommodation in ABO-incompatible kidney transplantation. Clin Transplant. 2005; 19: S76-85
|
|
|
|
|
|
9）Mannami R, Mitsuhata N. Improved outcomes after ABO-incompatible living-donor kidney transplantation after 4 weeks treatment with mycophenolate mofetil. Transplantation. 2005; 79: 1756-8
|
|
|
|
|
|
10）Sawada T, Fuchinoue S, Teraoka S. Successful A1-to-O ABO-incompatible kidney transplantation after a preconditioning regimen consisting of anti-CD20 monoclonal antibody infusions, splenectomy, and double-filtration plasmapheresis. Transplantation. 2002; 74: 1207-10
|
|
|
|
|
|
11）Tydén G, Kumlien G, Fehrman I. Successful ABO-incompatible kidney transplantations without splenectomy using antigen-specific immunoadsorption and rituximab. Transplantation. 2003; 76: 730-1
|
|
|
|
|
|
12）Warren DS, Zachary AA, Montgomery RA, et al. Successful renal transplantation across simultaneous ABO incompatible and positive crossmatch barriers. Am J Transplant. 2004; 4: 561-8
|
|
|
|
|
|
13）Saito K, Nalagawa Y, Takahashi K, et al. Pinpoint targeted immunosuppression: Anti-CD20/MMF desensitization with anti-CD25 in successful ABO incompatible kidney transplantation without splenectomy. Xenotransplant. 2006; 13: 111-7
|
|
|
|
|
|
14）Yamamoto F, Clausen H, Hakomori S, et al. Molecular genetic basis of the histo-blood group ABO system. Nature. 1990; 345: 229-33
|
|
|
|
|
|
15）Tasaki M, Yoshida Y, Takahashi K, et al. Identification and characterization of major proteins carrying ABO blood group antigens in the human kidney. Transplantation. 2009; 87: 1125-33
|
|
|
|
|
|
16）Irei T, Ohdan H, Asahara T, et al. The persistent elimination of B cell responding to blood group A carbohydrates by synthetic group A carbohydrates and B-1 cell differentiation blockade: novel concept in preventing antibody-mediated rejection in ABO-incompatible transplantation. Blood. 2007; 110: 4567-75
|
|
|
|
|
|
17）Ohdan H, Swenson KG, Sykes M, et al. Mac1 negative B-1b phenotype of natural antibody-producing cells, including those responding to gal α 1,3 gal epitopes in α1,3-galactosyltransferase-deficient mice. J Immunol. 2000; 165: 5518-29
|
|
|
|
|
|
18）Takahashi K. Classifying rejection in particular acute antibody mediated rejection caused by ABO-blood group related antigens. ABO-incompatible kidney transplantation -Establishing a scientific framework-Amsterdam. Tokyo: Elsevier; 2007. Chapter 5. p.35-51
|
|
|
|
|
|
19）Takahashi K, Imai N, Saito K, et al. Mechanism of acute antibody-mediated rejection in ABO-incompatible kidney transplantation: Which anti-A/anti-B antibodies are responsible, natural or de novo? Transplantation. 2010; 89: 635-7
|
|
|
|
|
|
20）Iwasaki J, Miwa Y, Kobayashi T, et al. Comparative study on signal transduction in endothelial cells after anti-A/B and human leukocyte antigen antibody reaction: Implication of accommodation. Transplantation. 2012; 93: 378-85
|
|
|
|
|
|
21）Tanabe T, Ishida H, Tanabe K, et al. Endothelial chimerism after ABO-incompatible kidney transplantation. Transplantation. 2012; 93: 709-16
|
|
|
|
|
|
22）Liu Z, Xu B, Saito K, et al. Profiling of kidney vascular endothelial cell plasma membrane proteins by liquid chromatography-tandem mass spectrometry. Clin Exp Nephrol. 2013; 17: 327-37
|
|
|
|
|
|
23）Takahashi K, Saito K. ABO-incompatible kidney transplantation. Transplant Reviews. 2013; 27: 1-8
|
|
|
|
|